Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
The fund returned 3.40% in June 2025 after managing a major M&A deal dispute between Mayne Pharma and Cosette. While confident that the buyer has no legal grounds to walk away, the fund proactively trimmed its position to limit drawdown damage.
Full Quick Take
The fund returned 3.40% in June 2025 after managing a major M&A deal dispute between Mayne Pharma and Cosette. While confident that the buyer has no legal grounds to walk away, the fund proactively trimmed its position to limit drawdown damage.
